Riskpilot← Back to searchSign inGet full accessCONMED DENMARK ApS
APSActiveCVR 34092052Naverland 2, 1.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20115 employees
Revenue 2024
DKK 6,9M
+3% vs 2023
EBITDA margin
41.8%
+17% vs 2023
Equity ratio
77.6%
Financial strength
Net profit 2024
DKK 9,7M
+410% vs 2023
| Revenue | DKK 6,9M | +3% |
| EBITDA | DKK 2,9M | +17% |
| Net profit | DKK 9,7M | +410% |
| Total assets | DKK 23,4M | +6% |
| Equity | DKK 18,2M | -2% |
| Employees | 5 | — |
Legal name
CONMED DENMARK ApS
CVR number
34092052
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
27. december 2011
Share capital
DKK 80.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør eller af ét bestyrelsesmedlem eller af den samlede bestyrelse eller af to direktører i forening.
Company purpose
Selskabets formål er at udøve virksomhed med handel, service, industri og investering samt aktiviteter i tilknytning hertil.
Address
Naverland 2, 1.
Phone
+4543636460
Email
infoDK@conmed.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.465 | 10.973 | 11.140 | 10.504 | 9.744 | 8.606 | 8.154 | 8.812 | 5.377 | 6.640 | 6.312 | 6.628 | 6.851 |
| Staff expenses | -9.277 | -7.431 | -7.021 | -6.631 | -6.218 | -4.798 | -4.549 | -4.687 | -5.194 | -4.390 | -4.481 | -4.189 | -3.989 |
| EBITDA | 2.323 | 3.542 | 4.119 | 3.873 | 3.526 | 3.808 | 3.605 | 4.125 | 183 | 2.250 | 1.831 | 2.440 | 2.862 |
| Depreciation & amort. | -1.318 | -1.382 | -1.311 | -1.173 | -1.109 | -1.109 | -1.109 | -0 | -2 | -11 | -33 | -41 | -34 |
| EBIT | 1.006 | 2.160 | 2.809 | 2.700 | 2.417 | 2.699 | 2.496 | 4.125 | 182 | 2.240 | 1.798 | 2.398 | 2.827 |
| Net financials | -715 | 111 | 10 | 6.703 | -10 | 4.964 | 1.745 | 8.017 | 2.603 | 5.871 | 10 | 41 | 7.493 |
| Profit before tax | 291 | 2.271 | 2.818 | 9.403 | 2.408 | 7.663 | 4.241 | 12.143 | 2.785 | 8.111 | 1.808 | 2.439 | 10.321 |
| Tax | 88 | 571 | 730 | 685 | 552 | 589 | 549 | 914 | -78 | 483 | 404 | 545 | 654 |
| Net profit | 203 | 1.700 | 2.089 | 8.718 | 1.856 | 7.074 | 3.692 | 11.229 | 2.863 | 7.627 | 1.403 | 1.894 | 9.667 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 32.743 | 27.783 | 30.052 | 23.190 | 23.003 | 21.923 | 20.426 | 22.766 | 23.854 | 22.249 | 24.143 | 22.074 | 23.413 |
| Equity | 283 | 22.758 | 24.847 | 16.065 | 17.920 | 14.854 | 15.297 | 16.225 | 15.088 | 15.215 | 16.619 | 18.513 | 18.180 |
| Long-term debt | 20.776 | 0 | 0 | 0 | 0 | 0 | 0 | 186 | 375 | 0 | 0 | 0 | 0 |
| Short-term debt | 11.684 | 5.024 | 5.205 | 7.125 | 5.082 | 7.068 | 5.028 | 6.260 | 8.271 | 6.880 | 7.356 | 3.428 | 5.109 |
| Total debt | 32.460 | 5.024 | 5.205 | 7.125 | 5.082 | 7.068 | 5.028 | 6.446 | 8.646 | 6.880 | 7.356 | 3.428 | 5.109 |
EBITDA margin
41.8%
This company
15.8%
Market median
+165% vs market
20122024
Equity ratio
77.6%
This company
38.2%
Market median
+103% vs market
20122024
Return on equity
53.2%
This company
18.4%
Market median
+189% vs market
20122024
Net profit margin
141.1%
This company
8.1%
Market median
+1642% vs market
20122024
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20122024
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2011-12-27 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
XP Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
BV Management | Management | 2012 | — | — |
LE | Founder | 2011 | — | — |
JM Management | Management | 2018 | — | — |
RD Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
LA Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
PE Management | Management | 2012 | — | — |
TM Management | Management | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2012 | — | — | |
| Chairman | 2026 | — | — | |
| Board of Directors | 2012 | — | — | |
| Chairman | 2011 | — | — | |
| Chairman | 2023 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2015 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CONMED DENMARK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Xavier Planas De Maruri | Chief Executive Officer | 0 companies |
| Bo Vendelboe | Management | 0 companies |
| Lars Eduard Klarskov Petersen | Founder | 0 companies |
| Johonna M Pelletier | Management | 0 companies |
| Robert D. Shallish, Jr. | Chief Executive Officer | 0 companies |
| Luke Anthony Pomilio | Chief Executive Officer | 0 companies |
| Patric Eriksson | Management | 0 companies |
| Terence Matthew Berge | Management | 0 companies |
| Daniel S. Jonas | Chairman | 0 companies |
| Andrew David Kearns | Chairman | 0 companies |
| Linda Germaine Julienne Vanhassel | Board of Directors | 0 companies |
| Joseph C. Corasanti | Chairman | 0 companies |
| Heather Lynn Cohen | Chairman | 0 companies |
| Stéphane Jean Auguste Epinette | Chairman | 0 companies |
| Dominique Yves Eugène Marie Hazo | Board of Directors | 0 companies |
| Patrick Beyer | Board of Directors | 0 companies |